EYE REPUBLIC Ophthalmology Clinic (EYE REPUBLIC) has recently partnered with Novartis, one of the world’s innovative pharmaceutical companies and a global leader in generics, vaccines and consumer health products, that allow EYE REPUBLIC patients to avail of Ranibizumab treatments at 0% interest for three months when they use their BPI credit card.

 

 

Ranibizumab is the first and only drug shown in clinical trials to improve vision in a significant number of people suffering from AMD, or age-related macular degeneration, a condition where the macular (or central) retina develops degenerative lesions that can lead to vision loss if left untreated.  With Ranibizumab, patients gained vision and the ability to do daily activities and experienced a renewed sense of wellbeing and improved quality of life.

Photo shows (from left EYE REPUBLIC vitreous and retina specialist Dr. Edmin Michael Santos; Novartis marketing director Bob Segovia; EYE REPUBLIC president and CEO Dr. Manolette Roque; and EYE REPUBLIC purchasing officer Dr. Barbara Roque.

For more details, contact EYE REPUBLIC at +63917 817 2020 or +63917 807 2020 or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it or This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

This is a copy of the newspaper article printed on The Philippine Star on March 12, 2009.

< Prev		Next >